1. Home
  2. APLT vs CARS Comparison

APLT vs CARS Comparison

Compare APLT & CARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • APLT
  • CARS
  • Stock Information
  • Founded
  • APLT 2016
  • CARS 1998
  • Country
  • APLT United States
  • CARS United States
  • Employees
  • APLT N/A
  • CARS N/A
  • Industry
  • APLT Biotechnology: Pharmaceutical Preparations
  • CARS Motor Vehicles
  • Sector
  • APLT Health Care
  • CARS Consumer Discretionary
  • Exchange
  • APLT Nasdaq
  • CARS Nasdaq
  • Market Cap
  • APLT 971.6M
  • CARS 1.0B
  • IPO Year
  • APLT 2019
  • CARS 2017
  • Fundamental
  • Price
  • APLT $10.24
  • CARS $19.40
  • Analyst Decision
  • APLT Strong Buy
  • CARS Buy
  • Analyst Count
  • APLT 5
  • CARS 4
  • Target Price
  • APLT $12.50
  • CARS $23.00
  • AVG Volume (30 Days)
  • APLT 1.6M
  • CARS 532.5K
  • Earning Date
  • APLT 11-07-2024
  • CARS 11-07-2024
  • Dividend Yield
  • APLT N/A
  • CARS N/A
  • EPS Growth
  • APLT N/A
  • CARS N/A
  • EPS
  • APLT N/A
  • CARS 0.59
  • Revenue
  • APLT N/A
  • CARS $718,327,000.00
  • Revenue This Year
  • APLT N/A
  • CARS $7.00
  • Revenue Next Year
  • APLT $3,169.03
  • CARS $4.97
  • P/E Ratio
  • APLT N/A
  • CARS $32.70
  • Revenue Growth
  • APLT N/A
  • CARS 5.98
  • 52 Week Low
  • APLT $1.79
  • CARS $15.05
  • 52 Week High
  • APLT $10.62
  • CARS $21.24
  • Technical
  • Relative Strength Index (RSI)
  • APLT 73.26
  • CARS 79.48
  • Support Level
  • APLT $9.44
  • CARS $15.52
  • Resistance Level
  • APLT $9.98
  • CARS $16.46
  • Average True Range (ATR)
  • APLT 0.59
  • CARS 0.52
  • MACD
  • APLT 0.07
  • CARS 0.41
  • Stochastic Oscillator
  • APLT 83.12
  • CARS 99.40

About APLT Applied Therapeutics Inc.

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

About CARS Cars.com Inc.

Cars.com Inc is an online destination for buying and selling new and used vehicles. The company brands include Dealer Inspire, DealerRater, FUEL, Accu-Trade, PickupTrucks.com, CreditIQ, and NewCars.com., websites directed towards different consumer segments.

Share on Social Networks: